Why the Zimmer Biomet and LDR Deal Is a Big Win
Shares of LDR skyrocketed in Tuesday's session following the definitive agreement for Zimmer Biomet to acquire the company for $1 billion.
All Work
Chris Lange
Biogen Stumbles Over Missed Mid-Stage Results
Shares of Biogen slumped early in Tuesday's session following the release of less-than-favorable top-line results from its mid-stage clinical study evaluating opicinumab.
Why Earnings Were Not the Biggest Disappointment in Valeant’s Report
Valeant Pharmaceuticals International reported disappointing first-quarter financial results before the markets opened on Tuesday.
What to Expect From Lululemon Earnings
Lululemon Athletica is expected to report its fiscal first-quarter financial results before the markets open on Wednesday.
SEC Issues Charges on Pharma Insider Trading
The U.S. Securities and Exchange Commission (SEC) recently charged two men from Rhode Island with insider trading in the securities of deal targets being pursued by the pharmaceutical company where one of them worked.…
How Credit Suisse Views Major Pharma After ASCO
The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations at the conference.
SEC Charges New York Trader in Ponzi Scheme
The SEC has charged a New York City-based trader with defrauding investors by misrepresenting her investment track record, the profitability of her investments and her use of investor funds.
Elevate Credit Puts IPO Back on the Table
Elevate Credit decided to postpone its offering back in January, but now it is back on the table. The entire offering is valued up to about $91 million.
The 5 Biggest Biotech and Pharma Losers From ASCO
Some call the ASCO annual meeting the "Super Bowl for biotechs" because of the significance it holds for so many companies.
At Home Updates Finances in Most Recent IPO Filing
At Home Group has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Why ProNAi Could Be the Biggest Loser at ASCO
The annual meeting for ASCO is generally one of the biggest weeks of the year for the health care sector. However, there are inevitably winners and losers.
Why Vascular Biogenics Is One of the Biggest Winners From ASCO So Far
As the annual meeting for the American Society of Clinical Oncology (ASCO) is underway, we are starting to see some winners shake out from it. Currently one of the biggest winners is Vascular Biogenics…
Why Ocular Therapeutix Is Sinking Despite Mixed Results
Ocular Therapeutix shares plunged early on Monday following less-than-favorable results, although the news was not all bad.
How Analysts Rate Broadcom After Stellar Earnings Report
Broadcom exceeded EPS expectations for its first quarter operating as a combined company. After the report, the stock hit a new all-time high.
Why Analysts Are Getting More Bullish on Ciena
Ciena reported second-quarter fiscal 2016 results before markets opened Thursday. The company won out on this earnings report, and as a result analysts poured into the stock.
5 Companies That Destroyed Shareholders Last Week
Sarepta Therapeutics and Globalstar are among the companies that punished shareholder the most this past week.
The 3 Most Important Earnings of the Coming Week
24/7 Wall St. has put together a preview of Lululemon Athletica and a few other major companies reporting their quarterly results this week.
SEC Freezes Assets of Husband and Wife in Cancer Treatment Scam
The SEC has announced fraud charges and an asset freeze against a husband and wife accused of misusing money they raised from investors for the purpose of building and operating a new cancer treatment…
SEC Charges Advisor With Defrauding Investors
The U.S. Securities and Exchange Commission (SEC) charged a North Carolina-based investment adviser with defrauding investors.
5 Stocks on the Move After Employment Report
After a weaker than expected Employment Situation report, the broad markets took a downturn across the board in Friday’s trading session.